What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Incident"

Search information

Kineta, Inc.

Companies

"Incident"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

43 results

Newest first Best match first

KANT Kineta, Inc.

Quarterly report

to litigation or subject to claims incident to the ordinary course of business. Although the results of litigation and claims cannot be predicted

8 Aug 24

4:00pm

KANT Kineta, Inc.

Quarterly report

not a party to any other material legal proceedings. From time to time, however, Kineta may be a party to litigation or subject to claims incident

15 May 24

4:05pm

KANT Kineta, Inc.

Definitive proxy

posture, results from third-party assessments, progress towards pre-determined risk-mitigation-related goals, our incident response plan

26 Apr 24

4:00pm

KANT Kineta, Inc.

incident to the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, Kineta currently … ; foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business

21 Mar 24

4:06pm

KANT Kineta, Inc.

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts

Kineta data and analysis on file 28 Source: Globaldata: Epidemiology Market Size Forecast - 2027 Incident cases diagnosed (N) 8MM: US, France, Germany

Regulation FD Disclosure

t4g1 7qetds8o56a

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

nms3b1q10gre7ccx s6l

Quarterly report

3 Nov 23

4:04pm

1yysi3sqrx9e3ml

Entry into a Material Definitive Agreement

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Regulation FD Disclosure

kk7rvn l9tsky82

Quarterly report

11 Aug 23

4:07pm

Submission of Matters to a Vote of Security Holders

Quarterly report

11 May 23

5:22pm

dykrkfosur7duffwccfs

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

31 Mar 23

4:05pm

pl7nww3saww0wo oxj

Kineta Completes Reverse Merger with Yumanity Therapeutics

Kineta Completes Reverse Merger with Yumanity Therapeutics

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

pic1u2r9 0w64j9

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.